Home › Drugs by Condition › H › Hyperphosphatemia of Renal Failure › Sevelamer Pregnancy Warnings
Print Save or Share

Sevelamer Pregnancy and Breastfeeding Warnings

Sevelamer is also known as: Renagel, Renvela

Overview

If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Sevelamer while you are pregnant. It is not known if Sevelamer is found in breast milk. If you are or will be breast-feeding while you use Sevelamer, check with your doctor. Discuss any possible risks to your baby.

Sevelamer Pregnancy Warnings

Sevelamer has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryotoxicity and fetolethality. There are no controlled data in human pregnancy. Sevelamer is only recommended for use during pregnancy when benefit outweighs risk.

Sevelamer slightly increased prenatal mortality in rabbits receiving 10 times the recommended human dose (1g/kg/day, based on mg/kg), due to an increased incidence of early resorptions. In rats receiving doses 15 and 45 times the recommended human dose (1.5 and 4.5 g/kg/day, based on mg/kg), sevelamer caused reduced or irregular ossification of fetal bones, probably due to a reduced absorption of fat-soluble vitamin D.

Sevelamer Breastfeeding Warnings

There are no data on the excretion of sevelamer into human milk. The effects in the nursing infant are unknown.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

(web6)